Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data.

Pivneva, Irina; Balp, Maria-Magdalena; Geissbühler, Yvonne; Severin, Thomas; Smeets, Serge; Signorovitch, James; Royer, Jimmy; Liang, Yawen; Cornwall, Tom; Pan, Jutong; Danyliv, Andrii; McKenna, Sarah Jane; Marsland, Alexander M; Soong, Weily.

Afiliação

Pivneva I; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada. irina.pivneva@analysisgroup.com.
Balp MM; Novartis Pharma AG, Basel, Switzerland.
Geissbühler Y; Novartis Pharma AG, Basel, Switzerland.
Severin T; Novartis Pharma AG, Basel, Switzerland.
Smeets S; Novartis Pharma AG, Basel, Switzerland.
Signorovitch J; Analysis Group, Inc., Boston, MA, USA.
Royer J; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.
Liang Y; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.
Cornwall T; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.
Pan J; Analysis Group, Inc., 1190 Avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.
Danyliv A; Novartis Pharma AG, Basel, Switzerland.
McKenna SJ; Novartis Business Services, Dublin, Ireland.
Marsland AM; Salford Royal NHS Foundation Trust and University of Manchester, Salford, UK.
Soong W; AllerVie Health and AllerVie Clinical Research, Birmingham, AL, USA.